Global Theranostics Market || keyplayers Abott Laboratories Foundation Medicine, Inc., Oxford Cancer Biomarkers, Ltd.

Theranostics is referred to the fusion of diagnostics and drug therapy. It involves nanoscience to unite diagnostic and therapeutic applications to form a single agent, allowing for diagnosis, drug delivery, and treatment response monitoring. Theranostics helps in optimizing safety, effective results, and streamlining of drug development. It uses specific biological pathways in human body to acquire diagnostic images as well as to deliver a therapeutic dose of radiation to the patient.

Growing development of novel companion diagnostic tests to be used with available treatment options is factor driving growth of the global theranostics market. Additionally, increasing adoption of diagnostic tests by laboratories is a factor expected to foster growth of the target market over the forecast period. Furthermore, collaborations and partnerships by leading manufacturers in order to develop innovative companion diagnostics test is key factor supporting growth of the global theranostics market. However, stringent government regulations, coupled with inadequate reimbursement facilities are factors hindering growth of the global theranostics market.

Request free sample:-

Company Profiles

o    Thermo Fisher Scientific, Inc.*

  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies

o    Beckman Coulter, Inc.

o    Focus Diagnostics

o    AmeriPath, Inc.

o    Illumina, Inc.,

o    F.Hoffmann LA-Roche Ltd.,

o    Qiagen NV

o    Myriad Genetics, Inc.

o    Agilent Technologies

o    Abott Laboratories

o    Foundation Medicine, Inc.,

o    Oxford Cancer Biomarkers, Ltd.

Contact Us:

Mr. Alex (Sales Manager)

Prophecy Market Insights

Phone: +1 860 531 2701

+91 777 504 9802

Back to top button